Income tax expense · 2012–2025

Catalyst Pharmaceuticals income tax expense

$69.2M+32.1% · FY2025

Catalyst Pharmaceuticals (CPRX) reported $69.2M in income tax expense for fiscal 2025, +32.1% year on year.

$02012$02013$02014$02015$02016$02017$02018$1.5M2019−$33.1M2020$13.2M2021$21.6M2022$23.1M2023$52.4M2024$69.2M2025
Catalyst Pharmaceuticals — Income tax expense, 2012–2025
Fiscal yearIncome tax expenseChangeFiling
FY20252025-12-31$69.2M+32.1%Open →
FY20242024-12-31$52.4M+126.7%Open →
FY20232023-12-31$23.1M+6.8%Open →
FY20222022-12-31$21.6M+64.1%Open →
FY20212021-12-31$13.2M+$46.3MOpen →
FY20202020-12-31−$33.1M−$34.6MOpen →
FY20192019-12-31$1.5M+$1.5MOpen →
FY20182018-12-31$0$0Open →
FY20172017-12-31$0$0Open →
FY20162016-12-31$0$0Open →
FY20152015-12-31$0$0Open →
FY20142014-12-31$0$0Open →
FY20132013-12-31$0$0Open →
FY20122012-12-31$0—Open →

Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Income tax expense at companies of similar size

Full ranking by income tax expense →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Catalyst Pharmaceuticals income tax expense |url=https://companiesranked.com/en/company/catalyst-pharmaceuticals/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Catalyst Pharmaceuticals income tax expense. CompaniesRanked. https://companiesranked.com/en/company/catalyst-pharmaceuticals/income-tax-expense

BibTeX

@misc{companiesranked-en-company-catalyst-pharmaceuticals-income-tax-expense-2026,
  author       = {{CompaniesRanked}},
  title        = {{Catalyst Pharmaceuticals income tax expense}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/catalyst-pharmaceuticals/income-tax-expense}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001193125-26-071525 · February 25, 2026

{{cite web |title=Catalyst Pharmaceuticals income tax expense — 10-K (0001193125-26-071525) |url=https://www.sec.gov/Archives/edgar/data/1369568/000119312526071525/cprx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Catalyst Pharmaceuticals overview